Results
1
1 companies
argenx
Market Cap: €40.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€647.20
7D
7.5%
1Y
20.6%